Recurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access program

dc.authoridÇavuş, Bilger/0000-0003-2203-4255
dc.authoridEROL, CİHAN/0000-0003-3155-8798
dc.authoridKarasu, Zeki/0000-0002-4974-7944
dc.authorwosidKIYICI, Murat/AAI-4213-2021
dc.authorwosidKaymakoglu, Sabahattin/AAT-2362-2020
dc.authorwosidÇavuş, Bilger/N-5492-2019
dc.authorwosidEROL, CİHAN/GWU-8797-2022
dc.authorwosidKarasu, Zeki/W-1176-2018
dc.contributor.authorIdilman, R.
dc.contributor.authorDemir, M.
dc.contributor.authorAladag, M.
dc.contributor.authorKaymakoglu, S.
dc.contributor.authorErol, C.
dc.contributor.authorCavus, B.
dc.contributor.authorIliaz, R.
dc.date.accessioned2024-08-04T21:00:59Z
dc.date.available2024-08-04T21:00:59Z
dc.date.issued2018
dc.departmentİnönü Üniversitesien_US
dc.descriptionInternational Liver Congress (ILC) -- APR 11-15, 2018 -- Paris, FRANCEen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipEuropean Assoc Study Liveren_US
dc.identifier.endpageS301en_US
dc.identifier.issn0168-8278
dc.identifier.issn1600-0641
dc.identifier.startpageS301en_US
dc.identifier.urihttps://hdl.handle.net/11616/103994
dc.identifier.volume68en_US
dc.identifier.wosWOS:000461068601213en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherElsevier Science Bven_US
dc.relation.ispartofJournal of Hepatologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleRecurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access programen_US
dc.typeConference Objecten_US

Dosyalar